全文获取类型
收费全文 | 901篇 |
免费 | 139篇 |
国内免费 | 29篇 |
出版年
2020年 | 10篇 |
2019年 | 8篇 |
2018年 | 13篇 |
2017年 | 9篇 |
2016年 | 16篇 |
2015年 | 21篇 |
2014年 | 21篇 |
2013年 | 36篇 |
2012年 | 34篇 |
2011年 | 38篇 |
2010年 | 26篇 |
2009年 | 30篇 |
2008年 | 22篇 |
2007年 | 31篇 |
2006年 | 39篇 |
2005年 | 29篇 |
2004年 | 22篇 |
2003年 | 23篇 |
2002年 | 21篇 |
2001年 | 33篇 |
2000年 | 33篇 |
1999年 | 23篇 |
1998年 | 18篇 |
1997年 | 19篇 |
1996年 | 14篇 |
1995年 | 13篇 |
1994年 | 18篇 |
1993年 | 9篇 |
1992年 | 21篇 |
1991年 | 8篇 |
1990年 | 13篇 |
1989年 | 15篇 |
1988年 | 10篇 |
1987年 | 11篇 |
1986年 | 20篇 |
1985年 | 24篇 |
1984年 | 15篇 |
1983年 | 19篇 |
1982年 | 18篇 |
1981年 | 15篇 |
1980年 | 12篇 |
1979年 | 8篇 |
1978年 | 9篇 |
1977年 | 18篇 |
1976年 | 12篇 |
1975年 | 11篇 |
1974年 | 15篇 |
1973年 | 13篇 |
1971年 | 14篇 |
1966年 | 8篇 |
排序方式: 共有1069条查询结果,搜索用时 15 毫秒
111.
112.
Tumor necrosis factor receptor (TNFR)-associated factor 3 (TRAF3) is broadly involved in different receptor-mediated signaling pathways. Considerable progress was made recently in understanding the role of TRAF3 in T cell biology. Here we review these new findings about how TRAF3 participates in T cell development and function. The different roles of TRAF3 in distinct immune cells are also compared. That TRAF3 is required for T cell effector functions, and invariant Natural Killer T cell function and development, was unexpected. Another surprising finding is that TRAF3 normally restrains regulatory T cell development. It is now clear that TRAF3 regulates signaling to T cells not only through costimulatory members of the TNFR superfamily, but also through the T cell receptor complex, and cytokine receptors. The diverse roles it plays support the multifaceted nature of this molecule. How TRAF3 mediates integration of different signaling cascades is an important topic for future study. 相似文献
113.
Fundamental to behavior is the capacity to distinguish beneficial from detrimental environmental stimuli. In this issue of Neuron, a new study by Morrison et?al. shows that underlying these processes are qualitatively different dynamical interactions between brain structures involved in processing the value of environmental stimuli. 相似文献
114.
目的:研究功能矫形前伸大鼠下颌后浅层嚼肌细胞凋亡的变化规律,探讨功能矫形的肌肉改建机理。方法:选用50只5周龄Sprague-Dawley(SD)雄性大白鼠,随机分为实验组和对照组各25只。实验组大鼠戴自制上颌功能矫治嚣,引导下颌前伸,并打开咬合。利用RT-PCR方法检测两组大鼠浅层嚼肌Bcl-2和Bax基因表达情况,利用TUNEL方法检测浅层嚼肌细胞凋亡情况。结果:①Bcl-2和Bax基因表达随大鼠戴用矫治器时间的延长而升高,至第3周开始下降但仍高于对照组,但Bax的表达高于Bcl-2。Bax/Bcl-2比值随大鼠戴用矫治器时间的延长而升高,至第4周开始下降。②TUNEL实验结果显示浅层嚼肌细胞在戴用矫治器1天后,开始出现凋亡,随着时间延长而增加,至第3周达到顶峰,第4周开始下降。结论:①Bax/Bcl-2比值升高促进浅层嚼肌细胞凋亡。②功能矫形可引起浅层嚼肌细胞凋亡,导致肌肉的结构和功能发生适应性改建。 相似文献
115.
目的:探讨"应力-生长(改建)"在细胞水平上的体现,为功能矫形治疗和矫治效果的保持提供新思路和实验依据。方法:本实验选用20只4周龄,雄性SD大鼠随机分为8组。其中实验组大鼠经戊巴比妥麻醉后佩戴上颌斜面导板,对照组未佩用。依据时间不同又分为四组:1d,7d,14d,21d。采用RT-PCR技术分析各组大鼠翼外肌组织中肌分化相关基因MyoD、myogenin mRNA的表达变化。结果:未施加功能矫形力的大鼠翼外肌组织MyoD表达伴随其生长发育呈现递减趋势,实验组在第7 d出现表达上调。同时,力学刺激后实验组动物myogenin的表达与对照组相比较在14 d组出现明显上调。结论:功能矫形力作用于翼外肌组织可以诱导MyoD和myogenin的表达上调进而诱导成肌细胞的分化。 相似文献
116.
杨晓红景蓓蓓张胜海答敏张萍朱依娜 《现代生物医学进展》2011,11(7):1355-1358
目的:基于钙黄绿素-铜(Ⅱ)荧光体系测定乙酰半胱氨酸。方法:在pH=8.0的Na2HPO.412H2O-KH2PO4缓冲液中,以492 nm为激发波长,520 nm为发射波长测定乙酰半胱氨酸溶液的荧光强度。结果:在pH=8.0的Na2HPO.412H2O-KH2PO4缓冲液中,二价铜离子与钙黄绿素配位引起荧光猝灭。由于乙酰半胱氨酸中巯基上的硫离子与Cu2+的亲和力很强,可从钙黄绿素-铜(Ⅱ)的络合物中夺取铜离子而使钙黄绿素游离出来,从而使体系的荧光得以恢复,并且荧光恢复的程度与加入乙酰半胱氨酸的量在一定范围内成线性。结论:建立了一种测定乙酰半胱氨酸的荧光分析新方法,该方法的线性范围为6.0 10-6~1.4 10-5 mol/L,检出限为4.010-6 mol/L。 相似文献
117.
Graham P. Wallis J. W. Arntzen 《Evolution; international journal of organic evolution》1989,43(1):88-104
The crested newt has a widespread European distribution and encompasses four taxa recently elevated to full species: Triturus cristatus, T. carnifex, T. dobrogicus, and T. karelini. These are distinct on morphological, chromosomal, and isozymic grounds and have fairly sharp transition zones. A widespread survey (12 countries, 49 geographic sites, 210 individuals) of mtDNA variation (20–27 restriction enzyme sites mapped per individual) was made in order to 1) correlate mtDNA variation with morphological features defining the species, 2) determine the degree of differentiation within and among species, and 3) detect any introgression among species. The mtDNAs of these species were clearly differentiated (d = 3.9–7.1%). Additionally, geographic structuring was observed within T. carnifex and T. karelini, each displaying two divergent mitochondrial genome types (d = 3.5% and 4.7%, respectively). The other two (more northerly distributed) species were genetically homogeneous over most (T. cristatus) or all (T. dobrogicus) of their ranges. In the case of T. cristatus, one may infer bottlenecking as a result of Pleistocene glaciation events. This may also apply in part to T. dobrogicus, but high population connectedness and gene flow in this lowland river species may alone be sufficient for homogenization of mtDNA. Patterns of mtDNA variation were largely concordant with morphology; some interspecific mitochondrial gene flow was observed, but only close to or in the transition zones. Analyses of mapped restriction-site data by UPGMA and parsimony methods (using the closely related T. marmoratus as an outgroup) produce very similar dendrograms. The levels of divergence found concur with the systematics of the group, but the differentiation within T. carnifex and T. karelini is notable. 相似文献
118.
Pituitary prolactin, like growth hormone (GH) and several other protein hormones, shows an episodic pattern of molecular evolution in which sustained bursts of rapid change contrast with long periods of slow evolution. A period of rapid change occurred in the evolution of prolactin in primates, leading to marked sequence differences between human prolactin and that of nonprimate mammals. We have defined this burst more precisely by sequencing the coding regions of prolactin genes for a prosimian, the slow loris (Nycticebus pygmaeus), and a New World monkey, the marmoset (Callithrix jacchus). Slow loris prolactin is very similar in sequence to pig prolactin, so the episode of rapid change occurred during primate evolution, after the separation of lines leading to prosimians and higher primates. Marmoset prolactin is similar in sequence to human prolactin, so the accelerated evolution occurred before divergence of New World monkeys and Old World monkeys/apes. The burst of change was confined largely to coding sequence (nonsynonymous sites) for mature prolactin and is not marked in other components of the gene sequence. This and the observations that (1) there was no apparent loss of function during the episode of rapid evolution, (2) the rate of evolution slowed toward the basal rate after this burst, and (3) the distribution of substitutions in the prolactin molecule is very uneven support the idea that this episode of rapid change was due to positive adaptive selection. In the slow loris and marmoset there is no evidence for duplication of the prolactin gene, and evidence from another New World monkey (Cebus albifrons) and from the chimpanzee and human genome sequences, suggests that this is the general position in primates, contrasting with the situation for GH genes. The chimpanzee prolactin sequence differs from that of human at two residues and comparison of human and chimpanzee prolactin gene sequences suggests that noncoding regions associated with regulating expression may be evolving differently from other noncoding regions. 相似文献
119.
BACKGROUND: Biochemical testing for pheochromocytoma by measurement of fractionated plasma metanephrines is limited by false positive rates of up to 18% in people without known genetic predisposition to the disease. The plasma normetanephrine fraction is responsible for most false positives and plasma normetanephrine increases with age. The objective of this study was to determine if we could improve the specificity of fractionated plasma measurements, by statistically adjusting for age. METHODS: An age-adjusted metanephrine score was derived using logistic regression from 343 subjects (including 33 people with pheochromocytoma) who underwent fractionated plasma metanephrine measurements as part of investigations for suspected pheochromocytoma at Mayo Clinic Rochester (derivation set). The performance of the age-adjusted score was validated in a dataset of 158 subjects (including patients 23 with pheochromocytoma) that underwent measurements of fractionated plasma metanephrines at Mayo Clinic the following year (validation dataset). None of the participants in the validation dataset had known genetic predisposition to pheochromocytoma. RESULTS: The sensitivity of the age-adjusted metanephrine score was the same as that of traditional interpretation of fractionated plasma metanephrine measurements, yielding a sensitivity of 100% (23/23, 95% confidence interval [CI] 85.7%, 100%). However, the false positive rate with traditional interpretation of fractionated plasma metanephrine measurements was 16.3% (22/135, 95% CI, 11.0%, 23.4%) and that of the age-adjusted score was significantly lower at 3.0% (4/135, 95% CI, 1.2%, 7.4%) (p < 0.001 using McNemar's test). CONCLUSION: An adjustment for age in the interpretation of results of fractionated plasma metanephrines may significantly decrease false positives when using this test to exclude sporadic pheochromocytoma. Such improvements in false positive rate may result in savings of expenditures related to confirmatory imaging. 相似文献
120.
A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis 总被引:4,自引:0,他引:4 下载免费PDF全文
Spondyloepiphyseal dysplasia (SED) encompasses a heterogeneous group of disorders characterized by shortening of the trunk and limbs. The autosomal dominant SED type Kimberley (SEDK) is associated with premature degenerative arthropathy and has been previously mapped in a multigenerational family to a novel locus on 15q26.1. This locus contains the gene AGC1, which encodes aggrecan, the core protein of the most abundant proteoglycan of cartilage. We screened AGC1 for mutations and identified a single-base-pair insertion, within the variable repeat region of exon 12 in affected individuals from the family with SEDK, that introduces a frameshift of 212 amino acids, including 22 cysteine residues, followed by a premature stop codon. This is the first identification of an AGC1 mutation causing a human disorder. This finding extends the spectrum of mutated genes that may cause SED and thus will aid in the molecular delineation of this complex group of conditions. 相似文献